Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125293151 | 12529315 | 1 | I | 20160627 | 20160705 | 20160705 | EXP | US-ASTRAZENECA-2016SE70814 | ASTRAZENECA | 0.00 | F | Y | 49.00000 | KG | 20160706 | OT | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125293151 | 12529315 | 1 | PS | RHINOCORT AQUA | BUDESONIDE | 1 | Nasal | 32 MCG/ACTLLATION EVERY DAY IN EACH NOSTRIL | U | 20746 | NASAL SPRAY | ||||||||
125293151 | 12529315 | 2 | SS | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | U | 0 | 40 | MG | CAPSULE | QD | ||||||
125293151 | 12529315 | 3 | SS | TOPROL XL | METOPROLOL SUCCINATE | 1 | Oral | U | 0 | MODIFIED-RELEASE TABLET | |||||||||
125293151 | 12529315 | 4 | SS | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Oral | U | 21366 | TABLET | |||||||||
125293151 | 12529315 | 5 | SS | ZOMIG | ZOLMITRIPTAN | 1 | Oral | U | 0 | 5 | MG | TABLET | QD | ||||||
125293151 | 12529315 | 6 | SS | LYRICA | PREGABALIN | 1 | Oral | U | 0 | 100 | MG | CAPSULE | QD | ||||||
125293151 | 12529315 | 7 | SS | NEURONTIN | GABAPENTIN | 1 | Unknown | U | 0 | ||||||||||
125293151 | 12529315 | 8 | SS | ZYRTEC | CETIRIZINE HYDROCHLORIDE | 1 | Unknown | U | 0 | ||||||||||
125293151 | 12529315 | 9 | SS | PROTONIX | PANTOPRAZOLE SODIUM | 1 | Oral | U | 0 | 40 | MG | TABLET | QD | ||||||
125293151 | 12529315 | 10 | SS | XANAX | ALPRAZOLAM | 1 | Oral | 0.5MG EVERY 8 - 12 HOURS | U | 0 | .5 | MG | TABLET | ||||||
125293151 | 12529315 | 11 | SS | BACITRACIN STERILE | BACITRACIN | 1 | Unknown | 500 UNIT/GRAM EYE | U | 0 | OINTMENT | ||||||||
125293151 | 12529315 | 12 | C | ALBUTEROL SULFATE. | ALBUTEROL SULFATE | 1 | Respiratory (inhalation) | 2.5 MG/3 ML (0.083 %} SOLUTION FOR NEBULIZATION | 0 | NEBULISER SOLUTION | |||||||||
125293151 | 12529315 | 13 | C | AMLODIPINE BESILATE | AMLODIPINE BESYLATE | 1 | Oral | 0 | 5 | MG | TABLET | QD | |||||||
125293151 | 12529315 | 14 | C | BETAMETHASONE DIPROPIONATE. | BETAMETHASONE DIPROPIONATE | 1 | Topical | 0.05% APPLY BY TOPICAL ROUTE EVERY DAY A FEW DROPS TO THE AFFECTED AREA(S) AND MASSAGE LIGHTLY UN... | 0 | CUTANEOUS LIQUID | |||||||||
125293151 | 12529315 | 15 | C | BUTALBITAL ACETAMINOPHEN | 2 | Oral | 50 MG-325 MG TAKE 1 TO 2 TABLET BY ORAL ROUTE | 0 | TABLET | ||||||||||
125293151 | 12529315 | 16 | C | CALCIUM 500 | 2 | Unknown | 0 | 500 | MG | CAPSULE | BID | ||||||||
125293151 | 12529315 | 17 | C | CARAFATE | SUCRALFATE | 1 | Oral | 0 | 1 | G | TABLET | QID | |||||||
125293151 | 12529315 | 18 | C | COENZYME Q10 | UBIDECARENONE | 1 | Unknown | RED YEAST RICE 60 MG-600 MG CAPSULE TWO TIMES A DAY | 0 | CAPSULE | |||||||||
125293151 | 12529315 | 19 | C | FOLIC ACID. | FOLIC ACID | 1 | Oral | 0 | 1 | G | TABLET | QD | |||||||
125293151 | 12529315 | 20 | C | KLOR-CON M20 | POTASSIUM CHLORIDE | 1 | Oral | 0 | PROLONGED-RELEASE TABLET | ||||||||||
125293151 | 12529315 | 21 | C | LASIX | FUROSEMIDE | 1 | Oral | 0 | 40 | MG | TABLET | QD | |||||||
125293151 | 12529315 | 22 | C | LORATADINE. | LORATADINE | 1 | Oral | 0 | 10 | MG | TABLET | QD | |||||||
125293151 | 12529315 | 23 | C | MAXZIDE | HYDROCHLOROTHIAZIDETRIAMTERENE | 1 | Oral | 0 | 25 | MG | TABLET | QD | |||||||
125293151 | 12529315 | 24 | C | MAXZIDE | HYDROCHLOROTHIAZIDETRIAMTERENE | 1 | Oral | 0 | 37.5 | MG | TABLET | QD | |||||||
125293151 | 12529315 | 25 | C | MAXZIDE | HYDROCHLOROTHIAZIDETRIAMTERENE | 1 | Oral | 0 | 25 | MG | TABLET | QD | |||||||
125293151 | 12529315 | 26 | C | MONTELUKAST | MONTELUKAST SODIUM | 1 | Oral | 0 | 10 | MG | TABLET | QD | |||||||
125293151 | 12529315 | 27 | C | METHOTREXATE SODIUM. | METHOTREXATE SODIUM | 1 | Oral | 2.5 MG TAKE 5 TABLETS ON MONDAY ANDTHURSDAYS. | 0 | TABLET | |||||||||
125293151 | 12529315 | 28 | C | NIACIN. | NIACIN | 1 | Oral | 0 | 1000 | MG | PROLONGED-RELEASE TABLET | QD | |||||||
125293151 | 12529315 | 29 | C | PLAQUENIL | HYDROXYCHLOROQUINE SULFATE | 1 | Oral | 0 | 200 | MG | TABLET | BID | |||||||
125293151 | 12529315 | 30 | C | PREDNISONE. | PREDNISONE | 1 | Oral | 0 | 10 | MG | TABLET | QD | |||||||
125293151 | 12529315 | 31 | C | PYRIDIUM | PHENAZOPYRIDINE | 1 | Oral | 0 | 200 | MG | TABLET | TID | |||||||
125293151 | 12529315 | 32 | C | REQUIP | ROPINIROLE HYDROCHLORIDE | 1 | Oral | 0 | 3 | MG | TABLET | BID | |||||||
125293151 | 12529315 | 33 | C | SOMA | CARISOPRODOL | 1 | Oral | 350.0MG EVERY 4 - 6 HOURS | 0 | 350 | MG | TABLET | |||||||
125293151 | 12529315 | 34 | C | TRAMADOL. | TRAMADOL | 1 | Oral | 50.0MG AS REQUIRED | 0 | 50 | MG | TABLET | |||||||
125293151 | 12529315 | 35 | C | VALIUM | DIAZEPAM | 1 | Oral | 5.0MG AS REQUIRED | 0 | 5 | MG | TABLET | |||||||
125293151 | 12529315 | 36 | C | VENTOLIN HFA | ALBUTEROL SULFATE | 1 | Oral | 90.0UG AS REQUIRED | 0 | 90 | UG | TABLET | |||||||
125293151 | 12529315 | 37 | C | VITAMIN D3 | CHOLECALCIFEROL | 1 | Oral | 2000 UNIT DAILY | 0 | TABLET | |||||||||
125293151 | 12529315 | 38 | C | VITAMIN E400 | 2 | Unknown | TAKE ONE TABLET | 0 | TABLET |
Indications of drugs used
no results found |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125293151 | 12529315 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125293151 | 12529315 | Amnesia | |
125293151 | 12529315 | Anxiety | |
125293151 | 12529315 | Bone lesion | |
125293151 | 12529315 | Drug hypersensitivity | |
125293151 | 12529315 | Gastritis | |
125293151 | 12529315 | Insomnia | |
125293151 | 12529315 | Migraine | |
125293151 | 12529315 | Pain | |
125293151 | 12529315 | Peptic ulcer | |
125293151 | 12529315 | Plasma cell myeloma | |
125293151 | 12529315 | Restless legs syndrome | |
125293151 | 12529315 | Rheumatoid arthritis | |
125293151 | 12529315 | Sjogren's syndrome | |
125293151 | 12529315 | Thinking abnormal | |
125293151 | 12529315 | Tympanic membrane perforation | |
125293151 | 12529315 | Vitreous floaters |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125293151 | 12529315 | 2 | 20161205 | 0 | ||
125293151 | 12529315 | 11 | 20160512 | 0 |